Atom Investors’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Other funds holding RARE
Atom Investors's RARE Position: Q3 2026 in Review
Atom Investors reduced its Ultragenyx Pharmaceutical (RARE) stake by 67% in Q3 2026, selling an estimated $2.78M and leaving 55,970 shares worth $841K. The position accounts for 0.05% of the portfolio, ranked #412.
Atom Investors first reported a position in RARE in Q1 2026 and has held it in 3 quarters since. The position peaked at $5.74M in Q2 2026. 268 funds tracked by Wall St. Rank hold RARE as of Q3 2026.
- Atom Investors held 55,970 shares of Ultragenyx Pharmaceutical worth $841K as of Q3 2026.
- Atom Investors sold 115,801 Ultragenyx Pharmaceutical shares in Q3 2026, an estimated $2.78M.
- Ultragenyx Pharmaceutical made up 0.05% of Atom Investors's portfolio in Q3 2026, its #412 holding.
- Atom Investors first reported a position in Ultragenyx Pharmaceutical in Q1 2026 and has held it in 3 quarters since.
- Atom Investors's Ultragenyx Pharmaceutical position peaked at $5.74M in Q2 2026.
- 268 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2026.
Based on Atom Investors's 13F filing for Q3 2026, filed 16 Nov 2026.